Monografie
Formulation Development of High Dose (-)-Epigallocatechin-3-gallate Immediate Release Tablets
- Sprache
-
Englisch
- Anmerkungen
-
Berlin, Freie Universität Berlin, Diss., 2015
- Identifier
-
1070218944
Thema
Arzneimittelentwicklung; Arzneimitteldesign; Hochschulschrift
Beteiligte Personen und Organisationen
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:54 MEZ
Objekttyp
- Monografie
Beteiligte
Ähnliche Objekte (12)
Formulation development strategies for oral extended release dosage form
Kombinatorische Synthese von amphiphilen Porphyrinoiden für die photodynamische Tumortherapie (PDT)
Novel formulation and processing aspects for compression coated tablets and for the compression of polymer-coated multiparticulates
Formulation and evaluation of water-insoluble matrix drug delivery systems and modelling of drug release
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Synthesis of 5-aminobarbituric acids and their conversion to hydantoins and bioactive phthalimido derivatives
Development of discriminative and predictive dissolution tests for immediate release oral dosage forms of poorly soluble drugs
The influence of drug core properties on drug release from extended release reservoir pellets
Formulation development of a highly concentrated suspension of Cilengitide
Combinative particle size reduction technologies for the formulation of poorly soluble drugs
Biodegradable implants with different drug release profiles
Floating Systems for Oral Controlled Release Drug Delivery
Formulation development strategies for oral extended release dosage form
Kombinatorische Synthese von amphiphilen Porphyrinoiden für die photodynamische Tumortherapie (PDT)
Novel formulation and processing aspects for compression coated tablets and for the compression of polymer-coated multiparticulates
Formulation and evaluation of water-insoluble matrix drug delivery systems and modelling of drug release
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Synthesis of 5-aminobarbituric acids and their conversion to hydantoins and bioactive phthalimido derivatives
Development of discriminative and predictive dissolution tests for immediate release oral dosage forms of poorly soluble drugs
The influence of drug core properties on drug release from extended release reservoir pellets
Formulation development of a highly concentrated suspension of Cilengitide
Combinative particle size reduction technologies for the formulation of poorly soluble drugs
Biodegradable implants with different drug release profiles
Floating Systems for Oral Controlled Release Drug Delivery
Formulation development strategies for oral extended release dosage form
Kombinatorische Synthese von amphiphilen Porphyrinoiden für die photodynamische Tumortherapie (PDT)
Novel formulation and processing aspects for compression coated tablets and for the compression of polymer-coated multiparticulates
Formulation and evaluation of water-insoluble matrix drug delivery systems and modelling of drug release
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Synthesis of 5-aminobarbituric acids and their conversion to hydantoins and bioactive phthalimido derivatives
Development of discriminative and predictive dissolution tests for immediate release oral dosage forms of poorly soluble drugs
The influence of drug core properties on drug release from extended release reservoir pellets
Formulation development of a highly concentrated suspension of Cilengitide
Combinative particle size reduction technologies for the formulation of poorly soluble drugs
Biodegradable implants with different drug release profiles